SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-22-211940
Filing Date
2022-08-04
Accepted
2022-08-04 09:32:54
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A d348245dsc14d9a.htm SC 14D9/A 20776
2 EX-99.(A)(5)(M) d348245dex99a5m.htm EX-99.(A)(5)(M) 20155
3 GRAPHIC g348245g0803212035543.jpg GRAPHIC 5157
4 GRAPHIC g348245g0803212035890.jpg GRAPHIC 3669
  Complete submission text file 0001193125-22-211940.txt   55304
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filed by) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Subject) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-89626 | Film No.: 221135128
SIC: 2834 Pharmaceutical Preparations